| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.45B | +15.2% |
| R&D Expense | $51.0M | +4.1% |
| SG&A Expense | $332.0M | +6.1% |
| Interest Expense | $109.0M | -1.8% |
| Pre-tax Income | $408.0M | +202.2% |
| Income Tax | $133.0M | +77.3% |
| Net Income | $273.0M | +387.5% |
| EPS (Basic) | $1.95 | +413.2% |
| EPS (Diluted) | $1.92 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.0M | -14.9% |
| Accounts Receivable | $611.0M | +60.4% |
| Inventory | $1.41B | +19.1% |
| Current Assets | $2.32B | +26.6% |
| Total Assets | $5.35B | +13.1% |
| Current Liabilities | $1.80B | +24.3% |
| Long-term Debt | $1.91B | +1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $489.0M | +62.5% |
| Capital Expenditures | $330.0M | -20.1% |
| Investing Cash Flow | -$309.0M | +1.3% |
| Financing Cash Flow | -$215.0M | -252.5% |
| Free Cash Flow | $159.0M | +242.0% |
| +405.3% |
| Total Liabilities |
| $4.38B |
| +9.4% |
| Stockholders' Equity | $952.0M | +34.8% |